Clinical Trials

60 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00574730 2023-09-14

CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma

Phase NA Completed

27 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT00846430 2023-08-30

Medical Treatment of "High-Risk" Neurofibromas

Other hematologic neoplasm

9 enrolled 9 charts

CNS

Neurofibroma, Neurofibromatosis 1

NCT02634294 2023-03-16

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Phase 2/3 Completed

30 enrolled

Graft vs Host Disease, Recurrence, Hematologic Neoplasms

NCT02218164 2022-10-07

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

8 enrolled 11 charts

Carcinoma, Squamous Cell, Neoplasm Metastasis, Skin Neoplasms

NCT01387763 2022-04-27

DALIAH

Phase 3 Completed

202 enrolled

Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT02112032 2021-05-05

Treatment of Advanced Melanoma With MK-3475 and Peginterferon

43 enrolled

Melanoma

NCT00525031 2020-09-23

Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients

55 enrolled 7 charts

Melanoma

NCT02379195 2020-01-22

Peginterferon and TIL Therapy for Metastatic Melanoma

Phase 1/2 Completed

12 enrolled 10 charts

Melanoma

NCT01933906 2019-01-04

Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response

12 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00014261 2018-03-30

Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00396019 2017-11-06

Study of PEG-Intron for Plexiform Neurofibromas

86 enrolled 6 charts

CNS

Neurofibroma, Plexiform

NCT01496807 2017-04-28

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

31 enrolled 11 charts

Melanoma

NCT00861406 2017-03-03

Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine

38 enrolled

Melanoma

NCT00548847 2016-10-26

Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation

Other hematologic neoplasm

15 enrolled 9 charts

Leukemia

NCT00050531 2016-05-11

High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)

Phase 3 Completed

94 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00303290 2015-11-26

PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML

76 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00045279 2013-06-05

PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00276523 2012-10-31

PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery

3 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00623402 2011-01-12

SoraPeg

55 enrolled

Melanoma

NCT01227356 2010-10-25

A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia

112 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00221702 2010-10-13

EADO

Phase 3 Completed

898 enrolled